- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01410461
Identifying Predictors of Treatment Success in Painful Bladder Syndrome (PBS)
Prospective Observational Study That Evaluates Predictor Tests for the Success of Myofascial Pelvic Floor Muscles for the Treatment of PBS
Study aims to: (1) evaluate the role of morphological and physiological characteristics of the pelvic floor, pain-related psychological and -psychophysical variables in prediction of the success of myofascial physical therapy (MPT) for the treatment of painful bladder syndrome Patients with clinical symptoms of PBS will undergo physical examination, sensory testing in the genital area, perineal ultrasound examination for the evaluation of the length of the levator muscles before MPT and following 10 consecutive sessions of MPT.
Improvement in clinical symptoms will be assessed and evaluated for correlations with psychophysical examinations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Chronic pelvic pain syndrome (CPPS) is highly prevalent, yet its etiology and the treatment approach are not clear. Painful bladder syndrome (PBS), a subtype of CPPS, is commonly treated by Myofascial physical therapy (MPT), however its efficiency is limited to portion of patients. The relative contribution of local factors such as pelvic anatomical and physiological function compared with systemic pain- related psychological and psychophysical parameters in the prediction of MPT outcome has not been illumined yet.
Hypothesis and aims: Assuming that MPT has mainly local effect its treatment success can be predicted by local impairment of pelvic anatomical and physiological function assessed pretreatment.
Study aims to: (1) evaluate the role of morphological and physiological characteristics of the pelvic floor, pain-related psychological and -psychophysical variables in prediction of MPT success, (2) to assess the effect of MPT on these parameters.
Methods: PBS patients will be evaluated for symptoms severity prior to MPT by: (1) pelvic physical examination for identification of trigger points, (2) self-report of pelvic pain intensity on visual analogue scale (VAS), (3) filling a questionnaire for urinary urgency symptoms, (4) evaluation of morphological and physiological characters of pelvic muscles floor by ultrasound and Doppler, respectively, (5) assessment of pain-related psychological variables (depression, somatization and pain catastrophizing) by questionnaires, and (6) psychophysical tests of experimental pain perception. Following 3 months treatment of MPT, patients will be reevaluated for the same tests. Treatment success will be determined by 30% reduction in pain and urinary urgency.
Expected results: Patients with shorter levator muscles and reduced blood flow in the pelvic region will benefit from MPT compared to patients with augmented pain sensitivity and higher depression, pain catastrophizing and somatization scores. MPT will elongate levator muscles and increased blood flow to the pelvic region that will be associated with the improvement in PBS symptoms.
Importance: The significance of the proposed study stems from its potential to extend conceptualizing of mechanisms associated with PBS and its treatment success.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel, 34987
- Zvolon Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age > 18 years old
- urinary frequency of at least 10 per 24 hr including one nighttime voiding
- complaints of bladder pain that has been present for at least 3 months
- pain intensity rated at least four on a VAS from 0 ''no pain at all'' to 10 ''worst imaginable pain'' during the previous month
- pelvic digital exam reveals at least three different TrPs in the levator ani muscles that are verbally confirmed.
Exclusion criteria:
- history of pelvic cancer or radiation
- pelvic or abdominal surgery within 3 months
- urinary tract infection within the last month
- diagnosis of fibromyalgia or irritable bowel disease
- diagnosis of neurologic disorder; diabetes; pregnancy;
- pelvic pain and/ or urgency symptoms presented only during menses.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with painful bladder syndrome
Patients with diagnosis of PBS Will be offered to take part in the following study.
|
Mechanical pain threshold: Threshold will be assessed, by using the von Frey filaments.
The lowest gram weight capable of inducing pain in two of three trials will be considered as a pain threshold Heat pain threshold (HPT): HPT will be measured using thermal sensory analyzer
Other Names:
Morphological measures of the pelvic muscles: Using a 3D 4-8MHz abdominal probe ultrasound testing will be performed.
The following parameters will be measured: (1) anteroposterior hiatal diameter; (2) lateral hiatal diameter; (3) levator ani thickness and length at 3 o'clock and 9 o'clock; (4) length of the obturator (5) length of the pubococcygeus muscle; (6) obturator thickness.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of pain level
Time Frame: 3 months
|
Following MPT it is expected that patients PBS symptoms will be improved as will be evaluated by VAS.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Elongation of levator ani muscles.
Time Frame: 3 months
|
Following MPT treatment it is expected that the levator ani muscles will be elongated as will be measured by perineal US.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Lior Lowenstein, MD, Rambam Health Care Campus
Publications and helpful links
General Publications
- Anderson RU, Sawyer T, Wise D, Morey A, Nathanson BH. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2009 Dec;182(6):2753-8. doi: 10.1016/j.juro.2009.08.033. Epub 2009 Oct 17.
- FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM; Urological Pelvic Pain Collaborative Research Network. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009 Aug;182(2):570-80. doi: 10.1016/j.juro.2009.04.022. Epub 2009 Jun 17.
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RMV-0232-10
- RMB-0232-10 (OTHER: Helsinki)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Painful Bladder Syndrome
-
University Of PerugiaUnknownPainful Bladder Syndrome (PBS)Italy
-
Case Western Reserve UniversityNot yet recruitingInterstitial Cystitis | Painful Bladder Syndrome (PBS)
-
Ain Shams UniversityCompletedInterstitial Cystitis | Painful Bladder Syndrome (PBS)Egypt
-
David SheynNot yet recruitingInterstitial Cystitis | Painful Bladder Syndrome | Painful Bladder Syndrome (PBS)
-
University of Alabama at BirminghamWashington University Early Recognition CenterCompleted
-
Watson PharmaceuticalsCompletedInterstitial Cystitis | Painful Bladder SyndromeUnited States
-
IRCCS Policlinico S. MatteoCompletedInterstitial Cystitis | Painful Bladder SyndromeItaly
-
NorthShore University HealthSystemCompletedInterstitial Cystitis | Painful Bladder Syndrome | Bladder Pain Syndrome | Low Dose Naltrexone | Low-dose Naltrexone | NaltrexoneUnited States
-
Loyola UniversityInterstitial Cystitis Association (ICA)CompletedInterstitial Cystitis | Painful Bladder SyndromeUnited States
-
National Institute of Diabetes and Digestive and...University of PennsylvaniaCompletedInterstitial Cystitis | Painful Bladder SyndromeUnited States, Canada
Clinical Trials on quantitive sensory testing
-
Nantes University HospitalTerminatedChronic Pelvic Pain | Chronic Perineal PainFrance
-
Weill Medical College of Cornell UniversityMassachusetts General HospitalRecruitingPain, Postoperative | Sensation Disorders | Pain, Chronic | Sensory Disorder | Phantom Pain | Phantom Sensation | Sensation, Phantom | Sensory Defect | NumbnessUnited States
-
Temple UniversityShriners Hospitals for Children; University of DelawareUnknown
-
M.D. Anderson Cancer CenterAmerican Cancer Society, Inc.Completed
-
Region Örebro CountyAalborg UniversityCompleted
-
University of California, Los AngelesCompleted
-
Massachusetts General HospitalHarvard Medical School (HMS and HSDM); Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedChronic Pain | Sleep Apnea | Cardiac Dysfunction | Neurocognitive DiseaseUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingChronic Pain | Sickle Cell Disease
-
Julia FinkelCompletedSCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)United States
-
University Hospital, BrestCompletedSensitive SkinFrance